...
首页> 外文期刊>Polymer bulletin >Novel polysaccharides-based nanoparticle carriers prepared by polyelectrolyte complexation for protein drug delivery
【24h】

Novel polysaccharides-based nanoparticle carriers prepared by polyelectrolyte complexation for protein drug delivery

机译:通过聚电解质络合制备的新型基于多糖的纳米粒子载体,用于蛋白质药物的递送

获取原文
获取原文并翻译 | 示例
           

摘要

Polyelectrolyte complexation, as one simple and promising method for preparing nanoparticles, is employed to find the use in the delivery of protein drugs. Using this method, we fabricated one kind of novel nanoparticles based on two natural polysaccharides, which are the negatively charged carboxymethyl pachyman (CMP) and the positively charged chitosan (CS). The major effect factors on the average particle size, polydispersity, and zeta potential of the nanoparticles were studied. The research indicated that the physicochemical properties of the nanoparticles were deeply affected by the molecular weight, concentration, and the ionic content of two polysaccharides. The mean particle size of CMP/CS nanoparticles was almost in the range of 100-200 nm for various preparation conditions. The morphology of nanoparticles characterized by a transmission electron microscope was spherical in shape with smooth surface structure. In order to study the feasibility of these nanoparticles as oral protein delivery carriers, the encapsulation efficiency of CMP/CS nanoparticles for bovine serum albumin (BSA) was evaluated for optimized condition. It turned out that the encapsulation efficiency of BSA-loaded CMP/CS nanoparticles varied from 30.1 to 52.9% depending on the initial loading concentration of BSA as well as the concentration of CMP and CS employed in particle formation, which indicated that the concentration of polymers and drugs were all contributed to the encapsulation efficiency of nanoparticles. This report opened up another interesting perspective to develop these natural polysaccharides with emerging new applications, which have great potentials in application in the nanoparticulate delivery system.
机译:聚电解质络合是制备纳米颗粒的一种简单而有前途的方法,用于发现蛋白质药物的递送用途。使用这种方法,我们基于两种天然多糖(带负电荷的羧甲基保夫曼(CMP)和带正电荷的壳聚糖(CS))制备了一种新型的纳米颗粒。研究了影响纳米粒子平均粒径,多分散性和ζ电势的主要因素。研究表明,纳米粒的理化性质受到两种多糖的分子量,浓度和离子含量的深远影响。对于各种制备条件,CMP / CS纳米颗粒的平均粒径几乎在100-200 nm的范围内。用透射电子显微镜表征的纳米颗粒的形态为球形,具有光滑的表面结构。为了研究这些纳米颗粒作为口服蛋白质递送载体的可行性,针对最佳条件评估了CMP / CS纳米颗粒对牛血清白蛋白(BSA)的包封效率。结果表明,BSA负载的CMP / CS纳米颗粒的包封效率从30.1%到52.9%不等,这取决于BSA的初始负载浓度以及颗粒形成中所用的CMP和CS的浓度,这表明聚合物的浓度药物都对纳米颗粒的包封效率有贡献。该报告开辟了另一种有趣的观点,以开发具有新兴应用的天然多糖,这些天然多糖在纳米微粒递送系统中具有巨大的应用潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号